Current Molecular Pharmacology
Title: Editorial [Hot Topic: Evidence and Significance of Non-Targeted Effects of Ionizing Radiation (Guest Editor: Nobuyuki Hamada)]
Volume: 4
Author(s): Nobuyuki Hamada
Affiliation:
Export Options
About this article
Cite this article as:
Hamada Nobuyuki, Editorial [Hot Topic: Evidence and Significance of Non-Targeted Effects of Ionizing Radiation (Guest Editor: Nobuyuki Hamada)], Current Molecular Pharmacology 2011; 4 (2) . https://dx.doi.org/10.2174/1874467211104020078
DOI https://dx.doi.org/10.2174/1874467211104020078 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug Metabolism and Pharmacokinetics in Support of Drug Design
Current Pharmaceutical Design Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung Carcinoma
Current Cancer Drug Targets The Sodium-Iodide Symporter
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer
Current Drug Targets Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women
Mini-Reviews in Medicinal Chemistry Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets Allelic Variations in 5, 10-Methylenetetrahydrofolate Reductase Gene and Susceptibility to Cervical Cancer in Indian Women
Drug Metabolism Letters Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1
Anti-Cancer Agents in Medicinal Chemistry Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
Current Cancer Therapy Reviews Molecular Aspects of Intestinal Radiation-Induced Fibrosis
Current Molecular Medicine MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Diagnostic Accuracy of Ultrasound for the Evaluation of Lateral Compartment Lymph Nodes in Papillary Thyroid Carcinoma
Current Medical Imaging Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
Current Cancer Drug Targets Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia
Current Cancer Drug Targets Targeting: The ADEPT Story So Far
Current Drug Targets Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors
Current Cancer Drug Targets